News

Sandoz, a Novartis company, is the first in the US to receive the approval through the new FDA biosimilars pathway established under the Biologics Price Competition and Innovation

The companies will conduct a study assess the clinical accuracy of spectral imaging technology with low radiation dose to measure breast density, potentially increasing accuracy of cancer detection

The anti-blood clotting drug apixaban can be used to treat venous thromboembolism (VTE) in adults, which is used to describe deep vein thrombosis (DVT) and pulmonary embolism (PE).

People familiar with the matter were reported by Reuters as saying that GSK confirmed the dismissal was for wrongdoing and misconduct that took place before mid-2013. However, the

The prodrug for isavuconazole, Cresemba has been approved for use in patients aged 18 years and above in the treatment of zygomycosis, which are life-threatening fungal infections predominantly

Under the terms of the agreement, TG Therapeutics will make an up-front payment as well as make development and sales-based milestone payments and will pay a tiered single

The grant has been given to clinically advance Irofulven for the treatment of metastatic castration resistant prostrate cancer (mCRPC) by utilising a highly predictive biomarker for the drug

SuppreMol is involved in development of treatment options for autoimmune and allergic diseases. Besides owning and operating SuppreMol’s Munich operations, Baxter will also own SuppreMol’s complete early-stage development

CRPS is a condition characterised by severe pain in a limb, accompanied by autonomic, sensory, motor and trophic changes. In few patients, the chronic pain can lead to